Amb a 1-specific immune receptor

The term "Amb a 1-specific immune receptors" refers broadly to immune recognition molecules — mainly IgE and IgG antibodies and T cell receptors — that specifically bind to Amb a 1, the major allergen from ragweed pollen[1][4]. These receptors are central to the pathogenesis of ragweed pollen allergy. IgE binding to Amb a 1 on mast cells and basophils leads to allergic inflammation, while T cell receptors recognizing Amb a 1 peptides drive Th2-mediated immune responses characteristic of allergic disease[1][4]. Monitoring Amb a 1-specific IgE is a common diagnostic and therapeutic biomarker, and interventions such as allergen immunotherapy aim to shift the immune response away from pathogenic IgE-mediated mechanisms toward protective or tolerogenic pathways[4]. There is no single gene, protein, or molecule designated as "Amb a 1-specific immune receptor"; instead, the term aggregates a group of adaptive immune receptors specific for different epitopes of this allergen. If you are seeking a canonical, structured target entry, neither "Amb a 1-specific immune receptors" nor similar terms are recognized as precise molecular targets; instead, refer to immunoglobulin E (IgE) recognizing Amb a 1, or T cell receptor recognizing Amb a 1 epitope, as applicable.

Other names

Amb a 1-specific IgE antibodiesAmb a 1-specific T cell receptorsAmb a 1-specific immunoglobulins

For allergen immunotherapy: induction of immune tolerance, skewing towards a Th1 response, reduction in IgE production[4]. For immunomodulatory therapies: stimulation of alternative immune pathways (e.g., TLR9 stimulation)[4].